Detalhe da pesquisa
1.
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.
Blood
; 131(8): 855-863, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203585
2.
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
Blood
; 129(24): 3175-3183, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468797
3.
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
Blood
; 129(24): 3165-3174, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28336527
4.
Selinexor, a selective inhibitor of nuclear export, inhibits human neutrophil extracellular trap formation in vitro.
Front Pharmacol
; 13: 1030991, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36506529
5.
Nuclear Export Inhibition for Radiosensitization: A Proof-of-Concept Phase 1 Clinical Trial of Selinexor (KPT-330) Combined With Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Int J Radiat Oncol Biol Phys
; 114(2): 250-255, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667526
6.
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Clin Cancer Res
; 23(6): 1552-1563, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649553
7.
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.
J Clin Oncol
; 34(34): 4142-4150, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26926685
8.
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.
J Clin Oncol
; 34(26): 3166-74, 2016 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458288
9.
Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.
Mol Cancer Ther
; 14(7): 1570-81, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934708